treatment
-
News
THE ECONOMIST | Dr Androulla Eleftheriou Discusses the Future of Thalassaemia Care
As genomics research moves from the bench to the bedside, clinical applications of genomics will affect even more areas of medicine, improving disease prevention, diagnosis, and treatment. Today, it is…
Read More » -
News
NEW REVIEW | Treatment Landscape of Rare Anaemias Is Shifting Rapidly
Writing in Frontiers in Medicine, the authors began by reviewing congenital and acquired forms of anaemia. Those include sickle cell disease (SCD) and hemolytic anemias (CHAs), both congenital, and autoimmune hemolytic…
Read More » -
News
Bluebird Bio Resumes Marketing Of Gene Therapy Zynteglo For β-Thalassaemia In Europe
The European Medicines Agency (EMA)’s safety committee (PRAC) has concluded that there is no evidence Zynteglo causes a blood cancer known as acute myeloid leukaemia (AML). Zynteglo, a gene therapy…
Read More »